Fact Based List:
Deborah L. Feinstein: Four design features of ACOs that raise red flags for antitrust agencies
Submitted by Charlene Ice on Fri, 07/25/2014 - 16:30
- preventing payers from steering patients to certain providers
- tying sales of the ACO’s services to the private payer’s purchase of other services from providers outside the ACO
- requiring exclusivity that discourages providers from contracting with payers outside the ACO
- restricting a payer’s ability to make available to enrollees information on cost, quality, efficiency, and performance
Notes: Deborah L. Feinstein is the Director of the Federal Trade Commission's Bureau of Competition. This list is from her presentation at the Fifth National ACO Summit.
Source: "Antitrust Enforcement in Health Care: Proscription, not Prescription," Fifth National Accountable Care Organization Summit – Washington, DC
Source URL: http://www.ftc.gov/system/files/documents/public_statements/...
List Ratings: |
Lists You Might Also Be Interested In
- Impact of ACO Affiliation on Antibiotic Prescribing for 5 Specialties: study
- Rosemary Day: 7 strategies for successful payer-provider ACO partnerships
- Greg Katsikas CPA: Top 5 Management and Organizational Risks in ACO Models
- When Stakeholders Estimate ACOs will Have a Material Impact in Their Marketplace
- The ACO Learning Network: General principles to ensure the continued success and participation of the Medicare Shared Savings Program (MSSP)
Login or register to post comments